Market Recognition SmithRx has been recognized as one of the Best in Business for two consecutive years by Modern Healthcare, highlighting its strong industry reputation and credibility which can facilitate trust-based sales conversations with prospective clients seeking proven, reputable PBM solutions.

Expanding Partnership Network Recent collaborations with organizations like UnitedAg, Costco Specialty Pharmacy, and Mark Cuban Cost Plus Drug Company demonstrate SmithRx's growing market presence and willingness to develop innovative, transparent cost-saving pilot programs—presenting opportunities to introduce similar health plans or employer groups to the company's offerings.

Innovative Program Growth The recent expansion of the Connect 360 Autoimmune Program with biosimilars such as Stelara and Humira indicates SmithRx’s focus on lowering drug costs for pharmaceutical benefit management, opening avenues for health systems or insurers aiming to cut costs on autoimmune treatments.

Financial Viability With revenues ranging between $100M and $250M and a recent funding of $60M, SmithRx demonstrates solid financial backing and growth potential, making it a competitive partner for organizations seeking innovative PBM solutions that emphasize transparency and cost savings.

Technology Leadership Using advanced tech stacks like Salesforce Force.com, LeanData, and modern collaboration tools positions SmithRx as a tech-savvy company, ideal for collaborations with digitally focused health benefit providers or employers looking to streamline pharmacy benefit management through innovative technology integrations.